Cspc Innovation Pharmaceutical Stock Debt To Equity
| 300765 Stock | 28.51 0.27 0.94% |
CSPC Innovation Pharmaceutical fundamentals help investors to digest information that contributes to CSPC Innovation's financial success or failures. It also enables traders to predict the movement of CSPC Stock. The fundamental analysis module provides a way to measure CSPC Innovation's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CSPC Innovation stock.
CSPC | Debt To Equity |
CSPC Innovation Pharmaceutical Company Debt To Equity Analysis
CSPC Innovation's Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
| Competition |
CSPC Total Stockholder Equity
Total Stockholder Equity |
|
According to the company disclosure, CSPC Innovation Pharmaceutical has a Debt To Equity of 0.0%. This is 100.0% lower than that of the Food Products sector and 100.0% lower than that of the Consumer Staples industry. The debt to equity for all China stocks is 100.0% higher than that of the company.
Did you try this?
Run Portfolio Comparator Now
Portfolio ComparatorCompare the composition, asset allocations and performance of any two portfolios in your account |
| All Next | Launch Module |
CSPC Fundamentals
| Return On Equity | 0.11 | ||||
| Return On Asset | 0.0603 | ||||
| Profit Margin | 0.25 % | ||||
| Operating Margin | (0.09) % | ||||
| Current Valuation | 38.75 B | ||||
| Shares Outstanding | 1.4 B | ||||
| Shares Owned By Insiders | 78.56 % | ||||
| Shares Owned By Institutions | 6.38 % | ||||
| Price To Book | 10.50 X | ||||
| Price To Sales | 19.79 X | ||||
| Revenue | 2.5 B | ||||
| Gross Profit | 1.13 B | ||||
| EBITDA | 654.85 M | ||||
| Net Income | 755.56 M | ||||
| Total Debt | 544.96 M | ||||
| Book Value Per Share | 2.74 X | ||||
| Cash Flow From Operations | 927.24 M | ||||
| Earnings Per Share | 0.37 X | ||||
| Target Price | 40.96 | ||||
| Number Of Employees | 1.89 K | ||||
| Beta | -0.14 | ||||
| Market Capitalization | 40.44 B | ||||
| Total Asset | 5.63 B | ||||
| Retained Earnings | 2.55 B | ||||
| Working Capital | 3.71 B | ||||
| Annual Yield | 0.01 % | ||||
| Net Asset | 5.63 B | ||||
| Last Dividend Paid | 0.27 |
About CSPC Innovation Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CSPC Innovation Pharmaceutical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CSPC Innovation using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CSPC Innovation Pharmaceutical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in CSPC Stock
CSPC Innovation financial ratios help investors to determine whether CSPC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CSPC with respect to the benefits of owning CSPC Innovation security.